These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3333933)

  • 1. Absorption kinetics of regular and isophane (NPH) insulin in the normal dog.
    Goeders LA; Esposito LA; Peterson ME
    Domest Anim Endocrinol; 1987 Jan; 4(1):43-50. PubMed ID: 3333933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption kinetics of regular, isophane, and protamine zinc insulin in normal cats.
    Wallace MS; Peterson ME; Nichols CE
    Domest Anim Endocrinol; 1990 Oct; 7(4):509-15. PubMed ID: 2261761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
    Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
    Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of time-action profiles for regular and NPH insulin using pharmacodynamic modeling.
    Woodworth JR; Howey DC; Bowsher RR
    Diabetes Care; 1994 Jan; 17(1):64-9. PubMed ID: 8112192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of porcine and human isophane (NPH) insulins in normal subjects.
    Owens DR; Jones IR; Birtwell AJ; Burge CT; Luzio S; Davies CJ; Heyburn P; Heding LG
    Diabetologia; 1984 Apr; 26(4):261-5. PubMed ID: 6376233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.
    Owens DR; Coates PA; Luzio SD; Tinbergen JP; Kurzhals R
    Diabetes Care; 2000 Jun; 23(6):813-9. PubMed ID: 10841002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucodynamics and pharmacokinetics of 70/30 vs. 50/50 NPH/regular insulin mixtures after subcutaneous injection.
    Krug EI; DeRiso L; Tedesco MB; Rao H; Korytkowski MT
    Diabetes Care; 2001 Sep; 24(9):1694-5. PubMed ID: 11522727
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures.
    Galloway JA; Spradlin CT; Nelson RL; Wentworth SM; Davidson JA; Swarner JL
    Diabetes Care; 1981; 4(3):366-76. PubMed ID: 7047113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption kinetics of short- and intermediate-acting insulins after jet injection with Medi-Jector II.
    Houtzagers CM; Berntzen PA; van der Stap H; Heine RJ; van der Veen EA
    Diabetes Care; 1988 Oct; 11(9):739-42. PubMed ID: 3066607
    [No Abstract]   [Full Text] [Related]  

  • 10. Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin.
    Olsson PO; Hans A; Henning VS
    Diabetes Care; 1987; 10(4):473-7. PubMed ID: 3304898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise augments the absorption of isophane (NPH) insulin.
    Thow JC; Johnson AB; Antsiferov M; Home PD
    Diabet Med; 1989; 6(4):342-5. PubMed ID: 2524341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence of Jusline following subcutaneous administration in healthy subjects.
    Al-Rubeaan KA; Al-Daghri NM; Alkharfy KM; Al-Attas OS; Hanif FS; Metias NS; Sabico SL
    Int J Clin Pharmacol Ther; 2008 Jul; 46(7):382-8. PubMed ID: 18793592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action profile of lispro is not blunted by mixing in the syringe with NPH insulin.
    Joseph SE; Korzon-Burakowska A; Woodworth JR; Evans M; Hopkins D; Janes JM; Amiel SA
    Diabetes Care; 1998 Dec; 21(12):2098-102. PubMed ID: 9839100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphology of palpably abnormal injection sites and effects on absorption of isophane(NPH) insulin.
    Thow JC; Johnson AB; Marsden S; Taylor R; Home PD
    Diabet Med; 1990 Nov; 7(9):795-9. PubMed ID: 2148131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.
    Bantle JP; Neal L; Frankamp LM
    Diabetes Care; 1993 Dec; 16(12):1592-7. PubMed ID: 8299455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the pharmacokinetics and metabolic effects of human regular and NPH insulin mixtures.
    Davis SN; Thompson CJ; Brown MD; Home PD; Alberti KG
    Diabetes Res Clin Pract; 1991 Aug; 13(1-2):107-17. PubMed ID: 1773708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-action profile of an oral enteric insulin formulation in healthy Chinese volunteers.
    Li J; Wang Y; Han L; Sun X; Yu H; Yu Y
    Clin Ther; 2012 Dec; 34(12):2333-8. PubMed ID: 23195963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal activity profiles of NPH and [Nepsilon-palmitoyl Lys (B29)] human insulins in subjects with IDDM.
    Radziuk J; Pye S; Bradley B; Braaten J; Vignati L; Roach P; Bowsher R; DiMarchi R; Chance R
    Diabetologia; 1998 Jan; 41(1):116-20. PubMed ID: 9498640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different absorption of isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique.
    Thow JC; Johnson AB; Fulcher G; Home PD
    Diabet Med; 1990 Aug; 7(7):600-2. PubMed ID: 2146067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
    Ahmed AB; Mallias J; Home PD
    Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.